Morning Market Movers
April 10, 2014 at 09:42 AM EDT
Celladon (NASDAQ: CLDN) rose 25.73% to $13.39 after the company received a breakthrough therapy designation from the FDA for MYDICAR. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.